Pipelines

Obesity drug slashes risk of heart attack or stroke ‘regardless of weight lost’

Obesity drug slashes risk of heart attack or stroke ‘regardless of weight lost’

Trending
Sophie Anderson

A five-year trial investigated whether semaglutide, a drug currently sold under the brand names Ozempic, Wegovy and Rybelsus, could reduce the risk ...